BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• 

  Biotech Bay

  4 Biotechs Ready to Kill the Market in 2018

  A look at a few biotechs which should outperform the market in 2018.

  December 29, 2017

   · 

  3 min read

   · 

  Mark Terry
• 

  Deals

  Australia’s Paragon Care Takes Out Insight Surgical, Medtech Solutions

  The group has bought 11 businesses in the past seven years.

  December 29, 2017

   · 

  1 min read
• 

  Deals

  LabCorp, Quest Face a More Difficult 2018 After Continued M&A Expansion

  Both companies are noted for growth through acquisition, and 2017 has been a very big year for LabCorp.

  December 29, 2017

   · 

  2 min read

   · 

  Mark Terry
• Policy

  Avadel Pharmaceuticals Issues 2018 Corporate Outlook

  The company announced its 2018 corporate objectives and financial expectations, including the commercial launch of Noctiva.

  December 29, 2017

   · 

  14 min read
• Pharm Country

  Recro Pharma Reports Inducement Grants for New Staff - Dec. 29, 2017

  The equity awards are subject to the individual’s continued service with Recro Pharma through the applicable vesting dates.

  December 29, 2017

   · 

  4 min read
• 

  Deals

  BD Completes Bard Acquisition, Creating New $16B Biotech Powerhouse

  The combined company is uniquely positioned to improve both the treatment of disease for patients and the process of care for health care providers.

  December 29, 2017

   · 

  7 min read
• Pharm Country

  Daxor Corporation Revises 2017 Dividend

  This dividend will be paid on Friday, January 12, 2018 to Daxor shareholders of record on Monday January 8, 2018.

  December 29, 2017

   · 

  1 min read
• Business

  Hebron Technology Co., Ltd. Reports Financial Results for the First Half of 2017

  Hebron Technology Co., Ltd. today announced its financial results for the six months ended June 30, 2017.

  December 29, 2017

   · 

  21 min read
• Business

  Critical Outcome Technologies Reports Fiscal 2018 Second Quarter Financial and Operating Results

  For the three-months ended October 31, 2017, the Company incurred a net loss of $1.781 million, or $0.11 per share, compared to a net loss of $0.748 million, or $0.05 per share, for the three-months ended October 31, 2016.

  December 29, 2017

   · 

  10 min read
• Policy

  Sirona Biochem Announces SGLT2 IND Submission Milestone

  Sirona Biochem announced today that partner Jiangsu Wanbang Biopharmaceuticals has confirmed an IND submission to CFDA for its SGLT2 inhibitor

  December 29, 2017

   · 

  2 min read